查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392037

魚皮病市場：依類型、治療類型、給藥途徑、配銷通路、地區

Fish Skin Disease Market, By Type (Ichthyosis vulgaris, X-linked recessive ichthyosis, Others ), By Treatment type (Corticosteroids, Emollients, Retinoids, Others ), By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球魚皮病市場價值為14億美元，預計將以9.8%的複合年成長率成長，到年終達到27億美元。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 14億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 9.80% 2030年市場規模預測 27億美元
圖 1. 2023 年依地區分類的魚皮病全球市場佔有率(%)
魚皮症市場-IMG1

魚皮病是一種導致大面積持續存在厚厚、乾燥、「魚鱗」狀皮膚的疾病。魚皮病是一種皮膚病，會導致皮膚乾燥、發癢、鱗狀、粗糙、發紅。症狀從輕微到嚴重不等。魚皮病可能只影響皮膚，但有些也可能影響內臟。魚類皮膚病有20多種。有些類型是出生時遺傳的，而有些則是成年後獲得的。治療有助於減少皮膚發紅、鱗屑厚度和搔癢。

市場動態：

魚皮病負擔的增加、公眾意識的提高、對安全有效的治療方法方法的需求不斷增加，以及市場參與企業推出新的治療方法和療法，正在推動全球魚皮病市場的成長。推動

例如，2023年4月，魚皮治療產品製造商Kerecis宣布推出MariGen Shield，這是一種將其魚皮移植物與矽膠接觸層相結合的解決方案，用於治療慢性和複雜的傷口。 。矽膠接觸層有助於將圓形移植物固定指定並保護肉芽傷口。

此外，2021 年 10 月，Kelesis 獲得了美國食品藥物管理局(FDA) 的 Omega3 SurgiBind 行銷核准。這是一種可植入的魚皮移植物，用於整形和重組手術。它在整形和重組手術中用於強化需要軟組織修復或加固的患者的軟組織。

本研究的主要特點

  • 本報告對全球魚皮病市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-20230）的市場規模和年複合成長率（CAGR%）。
  • 該報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 該報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 該報告根據以下參數（例如公司亮點、產品系列、主要亮點、業績和策略）介紹了全球魚皮病市場的主要企業。
  • 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
  • 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球魚皮病市場的各種策略矩陣來促進他們的決策。

目錄：

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 世界各地魚類皮膚病的負擔不斷增加
    • 缺乏人力資源意識
    • 安全有效治療方法的需求增加
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章魚皮病市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章魚皮病市場，依類型，2018-2030

  • 介紹
  • 魚類尋常性皮膚病
  • X連鎖隱性魚皮病
  • 其他（體染色體隱性遺傳先天性魚皮病等）

第6章魚皮病市場，依治療類型，2018-2030

  • 介紹
  • 皮質類固醇
  • 潤膚劑
  • 類視色素A
  • 其他（角質層分離劑等）

第 7 章 魚皮症市場，依給藥途徑，2018-2030 年

  • 介紹
  • 局部的
  • 口服
  • 胃腸外的

第8章魚皮病市場，依配銷通路分類，2018-2030

  • 介紹
  • 醫院藥房
  • 零售藥房
  • 線上藥房

第9章 2018-2030年魚皮病市場（依地區）

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 印度
  • 中國
  • 日本
  • 澳洲
  • 東南亞國協
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭形勢

  • GSK Plc.
  • AbbVie Inc.
  • Sonnet BioTherapeutics
  • Krystal Biotech
  • LEO Pharma
  • GALDERMA
  • GLENMARK PHARMACEUTICALS LTD.
  • Mayne Pharma Group Limited
  • Ortho Dermatologics
  • Cellegy Pharmaceuticals
  • Patagonia Pharmaceuticals, LLC
  • Crown Laboratories, Inc.

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5696

The Global Fish Skin Disease Market, was valued at US$ 1.4 Billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% to reach US$ 2.7 Billion by end of 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.80% 2030 Value Projection: US$ 2.7 Bn
Figure 1. Global Fish Skin Disease Market Share (%), By Region, 2023
Fish Skin Disease Market - IMG1

Ichthyosis is a medical condition that causes widespread and persistent thick, dry, "fish-scale" skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at birth, and others are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.

Market Dynamics:

The rise in burden of fish skin disease, the rise in awareness among people, the increase in demand for safe, effective treatments & therapies, and the introduction of novel treatments and therapies by market players are major factors expected to propel growth of the global fish skin disease market.

For instance, in April 2023, Kerecis, a manufacturer of fish skin-based therapeutic products announced the launch of the MariGen Shield, a solution that combines the company's fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position and help safeguard granulating wound

Moreover, in October 2021, Kerecis received the U.S. Food and Drug Administration (FDA) marketing authorization for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair or reinforcement in plastic or reconstructive surgery.

Key features of the study:

  • This report provides in-depth analysis of the global fish skin disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-20230), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market

Fish Skin Disease Market Detailed Segmentation:

  • By Type:
    • Ichthyosis vulgaris
    • X-linked recessive ichthyosis
    • Others (Autosomal recessive congenital ichthyosis, etc.)
  • By Treatment Type:
    • Corticosteroids
    • Emollients
    • Retinoids
    • Others (Keratolytics, etc.)
  • By Route of Administration:
    • Topical
    • Oral
    • Parenteral
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • GSK Plc.
    • AbbVie Inc.
    • Sonnet BioTherapeutics
    • Krystal Biotech
    • LEO Pharma
    • GALDERMA
    • GLENMARK PHARMACEUTICALS LTD.
    • Mayne Pharma Group Limited
    • Ortho Dermatologics
    • Cellegy Pharmaceuticals
    • Patagonia Pharmaceuticals, LLC
    • Crown Laboratories, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Fish Skin Disease, By Type
    • Market Fish Skin Disease, By Treatment Type
    • Market Fish Skin Disease, By Route of Administration
    • Market Fish Skin Disease, By Distribution Channel
    • Market Fish Skin Disease, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of fish skin disease across the globe
    • Lack of awareness among people
    • Increase in demand for safe and effective treatments/therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Fish Skin Disease Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fish Skin Disease Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Ichthyosis vulgaris
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • X-linked recessive ichthyosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Others (Autosomal recessive congenital ichthyosis, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)

6. Fish Skin Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Emollients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Retinoids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Others (Keratolytics, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)

7. Fish Skin Disease Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Fish Skin Disease Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Fish Skin Disease Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • India
  • China
  • Japan
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • GSK Plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
  • Sonnet BioTherapeutics
  • Krystal Biotech
  • LEO Pharma
  • GALDERMA
  • GLENMARK PHARMACEUTICALS LTD.
  • Mayne Pharma Group Limited
  • Ortho Dermatologics
  • Cellegy Pharmaceuticals
  • Patagonia Pharmaceuticals, LLC
  • Crown Laboratories, Inc.
  • Analyst Views

11. Section

  • Research Methodology
  • About us